Description: Uni-Bio Science Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of biological and chemical pharmaceutical products to treat human diseases in the People's Republic of China. The company provides GeneTime, a prescription biological drug for wound healing; GeneSoft, an EGF eye drop for dry eye syndrome, corneal damage, and post-operative healing; Pinup, a voriconazole tablet to treat severe fungal infections; and Bokangtai, a mitiglinide tablet for the treatment of Type 2 diabetes, as well as Boshutai, an oral anti-diabetic drug targeting patients with pre-diabetes condition. It is also developing prescription drugs, including rExendin-4 (Uni-E4) for Type 2 diabetes; and rhPTH 1-34 (Uni-PTH) for the treatment of osteoporosis in postmenopausal women, as well as Uni-GLP, a GLP-1 agonist, a non-insulin treatment candidate for the treatment of Type 2 diabetes. The company was founded in 2001 and is headquartered in Sha Tin, Hong Kong.
Home Page: www.uni-bioscience.com
No. 20 Science Park East Avenue
Sha Tin,
Hong Kong
Phone:
852 3102 3232
Officers
| Name | Title |
|---|---|
| Mr. Kingsley Leung AHKIoD, CFA, MSc | Exec. Chairman |
| Mr. Zhi Gang Zhao CPA, MSc | CEO & Exec. Director |
| Mr. Dawei Chen EMBA | Exec. Vice Chairman |
| Mr. Du Kai | Financial Controller |
| Ms. Wei Tian | Head of HR & Admin. Department |
| Mr. Wen Du An | Head of Marketing & Sales |
| Dr. Ya Lei Wen | Head of Manufacture Department |
| Mr. HuaNan Zhao | Head of Medical & Regulatory Affairs |
| Ms. Jing Li | Head of R&D Department |
| Ms. Wing Yan Ho A.C.I.S., A.C.S., ACIS, ACS (PE), ACS(PE), P.E. | Company Sec. |
Exchange: HK
Country: HK : Hong Kong
Currency: Hong Kong Dollar (HK$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.9381 |
| Price-to-Sales TTM: | 0.8768 |
| IPO Date: | 2001-11-12 |
| Fiscal Year End: | December |
| Full Time Employees: | 340 |